Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-27

Clinical Trial Update: Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System [NA]

View source ↗

Summary

This is a post-market surveillance clinical trial update for the BD WavelinQ EndoAVF System, currently recruiting to monitor performance in patients with end-st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BD WavelinQ EndoAVF System

Snippet

Sponsor: C. R. Bard | Conditions: Kidney Disease, End-Stage, End-stage Renal Disease | NA | Status: RECRUITING